# Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects

> **NCT01026545** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 39 (actual)

## Conditions studied

- Respiratory Tract Infections

## Interventions

- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo
- **DRUG:** PF-04287881
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01026545
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2011-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026545, "Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01026545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*